Related Experiment Video
Updated: Jan 7, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
Development of Insulin Bolus Calculators in Type 1 Diabetes using A Framework Based on Real-world Data, Digital Twins
IEEE Transactions on Bio-Medical Engineering
|December 25, 2025
Summary
Precise mealtime insulin bolus (MIB) dosing in type 1 diabetes (T1D) is improved using machine learning and digital twins. This framework enhances MIB algorithms with real-world data, leading to better glucose control and reduced hyperglycemia.
Area of Science:
- Biomedical Engineering
- Computational Biology
- Endocrinology
Background:
- Precise mealtime insulin bolus (MIB) dosing is critical for managing type 1 diabetes (T1D) and preventing glucose fluctuations.
- Traditional MIB formulas are limited as they do not integrate real-time continuous glucose monitoring (CGM) data.
- Existing CGM-integrated methods often rely on empirical rules or in-silico models, hindering real-world applicability.
Purpose of the Study:
- To investigate a framework combining machine learning (ML), digital twins (DTs), and real-world data to enhance MIB dosing algorithms for T1D.
- To assess, tune, and develop improved MIB dosing strategies beyond traditional and in-silico approaches.
- To leverage DTs for refining MIB formulas using real-world patient data.
Main Methods:
- Utilized ReplayBG, a DT for T1D, to evaluate a published linear ML model on real-world data from 30 subjects.
- Recalibrated the linear ML model using the real-world dataset to improve its performance.
- Trained and tested nonlinear gradient-boosting models (XGBoost, LightGBM) entirely on real data via DT simulations.
Main Results:
- DT-enhanced models demonstrated improved glucose control compared to the original in-silico model.
- Recalibrated linear and nonlinear models significantly increased time-in-range (up to 80.6% with LightGBM) and reduced time-above-range.
- Risk metrics associated with hypoglycemia and hyperglycemia showed notable improvement.
Conclusions:
- A DT-based framework utilizing real-world data effectively refines and develops MIB calculators for T1D.
- This approach achieves performance gains exceeding those of the original in-silico model.
- DTs facilitate the development, validation, and extension of MIB formulas, enabling practical ML-tailored solutions for T1D management.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
649
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
649
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Insulin Formulations: Types and Delivery
602
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
602
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
Diabetes: Management and Pharmacotherapy
844
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
844

